InvestorsHub Logo
Followers 22
Posts 1379
Boards Moderated 0
Alias Born 03/31/2017

Re: farrell90 post# 339882

Thursday, 01/14/2021 8:19:36 PM

Thursday, January 14, 2021 8:19:36 PM

Post# of 403741
I think so too fareell90. Exciting to get our next update with more information about the human trials for COVID.

Go Leo & Ipix!

It is my understanding that a part of the IND process is reviewing, tweeking, and approving the proposed protocol.

The protocol for Brilacidin should be set in place now. I would be surprised if the FDA would make changes since they just approved the protocol a few weeks ago.

I do not believe we will have any more delays and the next PR should be to announce the human clinical trial sites.

GLTA Farrell


Innovation Pharmaceuticals’ Brilacidin for the Treatment of COVID-19 Receives FDA Fast Track Designation

FDA Grants IND Approval for Phase 2 Clinical Trial of Innovation Pharmaceuticals - Brilacidin for Treating
COVID-19

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News